AstraZeneca's Three-in-One COPD Inhaler Succeeds in Phase III Trial Post author:Sam Post published:January 25, 2018 Post category:BioPharma Astra has Glaxo and its COPD treatment Trelegy Ellipta squarely in its sights. Source: BioSpace You Might Also Like Booming Rho to Go on 40-Person+ Hiring Binge September 18, 2017 Ceapro Reports 2016 Financial Results And Provides Corporate Update April 5, 2017 <b>John Adamou</b> Named Vice President Of Corporate & Business Development At <b>rHEALTH</b> And <b>DNA Medicine Institute</b> January 30, 2017
<b>John Adamou</b> Named Vice President Of Corporate & Business Development At <b>rHEALTH</b> And <b>DNA Medicine Institute</b> January 30, 2017
